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Multicavity halloysite–amphiphilic cyclodextrin
hybrids for co-delivery of natural drugs into
thyroid cancer cells†
M. Massaro,a S. Piana,a C. G. Colletti,a R. Noto,a S. Riela,*a C. Baiamonte,b
C. Giordano,b G. Pizzolanti,b G. Cavallaro,c S. Miliotoc and G. Lazzara*c
Multicavity halloysite nanotube materials were employed as simultaneous carriers for two diﬀerent natural
drugs, silibinin and quercetin, at 6.1% and 2.2% drug loadings, respectively. The materials were obtained by
grafting functionalized amphiphilic cyclodextrin onto the HNT external surface. The new materials were
characterized by FT-IR spectroscopy, SEM, thermogravimetry, turbidimetry, dynamic light scattering and
z-potential techniques. The interaction of the two molecules with the carrier was studied by HPLC
measurements and fluorescence spectroscopy, respectively. The release of the drugs from HNT–amphiphilic
cyclodextrin, at two different pH values, was also investigated by means of UV-vis spectroscopy. Biological
assays showed that the new complex exhibits anti-proliferative activity against human anaplastic thyroid
cancer cell lines 8505C. Furthermore, fluorescence microscopy was used to evaluate whether the carrier was
uptaken into 8505C thyroid cancer cell lines. The successful results revealed that the synthesized multicavity
system is a material of suitable size to transport drugs into living cells.
Introduction
In recent years, there has been increasing interest in both life
and materials science to use nanocontainers as carriers for the
encapsulation and delivery of drug molecules.
Halloysite nanotubes (HNTs) are a biocompatible alumino-
silicate clay, with a hollow tubular structure consisting of silica
on the outer surface and alumina at the innermost surface.1
HNTs and functionalized-HNTs (f-HNTs) are capable of entrap-
ping a variety of active agents within the inner lumen as well
as at the external surface, followed by their retention and slow
release.2 Due to their appealing characteristics, various exciting
applications have been proposed for these nanomaterials. For
instance, biomedical applications of HNTs include their use as
gene delivery systems, cancer cell isolation, stem cell isolation,
ultrasound contrast agents, bone implants, teeth fillers, cosmetics
and controlled drug delivery.3–8
Cyclodextrins (CDs) are very promising materials in several
fields. It is known that these macrocyclic compounds form
inclusion complexes with small- and medium-sized organic
molecules and the complexation reactions that are involved
are highly important in drug delivery systems.9 Furthermore,
it was demonstrated that the use of amphiphilic cyclodextrins
in drug delivery applications allows the increase of the range of
potential drugs that can be encapsulated in the CD cavity.10
Recently we reported the first example of a new drug delivery
system based on HNTs covalently linked to modified-cyclodextrin
units employed as carriers for polyphenolic compounds like
curcumin.11
Polyphenolic compounds, like flavonoids, that are ubiqui-
tously distributed in plants have attracted considerable interest
due to their wide variety of biochemical and pharmacological
properties.12,13 Unfortunately, their concentration in the blood
circulation is likely to be low because they are sparingly soluble
in water and chemically unstable in physiological medium.14–16
In order to protect these bioactive compounds against
degradation factors and to enhance the bioavailability, various
encapsulation and complexation methods are used.
In the present paper, we describe the synthesis and the
characterization of a novel hybrid based on HNTs covalently
linked to amphiphilic-cyclodextrin units. The advantages of
multifunctional nanocarriers with the presence of two cavities
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oﬀers the remarkable possibility for a simultaneous encapsulation
of one or more drug molecules with diﬀerent physico-chemical
properties, followed by a diﬀerent path release in agreement with
the cavity that interacts with the drugs. Therefore, in order to
employ the new system as a drug carrier we also studied its
simultaneous interaction with two molecules, namely quercetin
and silibinin, that possess diﬀerent sizes and shapes (Fig. 1).
Indeed, co-delivery has attracted more and more attention
because it is known that compared to conventional single-agent
treatment, multi-agent therapy can promote synergism of diﬀer-
ent drugs, increase therapeutic target selectivity, and overcome
drug resistance through distinct mechanisms of action.17
Results and discussion
Pristine halloysite was transformed as described into f-HNT-CD
1,10 and we used this material as a scaﬀold for the covalent
linkage of alkyl thiols 2a–d by thiol–ene reaction between vinyl
groups on CDs and –SH groups on thiols (Scheme 1).
The reaction of 1 with alkyl thiols 2 was carried out by
irradiation with UV light, from the Hg lamp, using toluene as
solvent, in quartz vials at room temperature under an argon
atmosphere. After 24 h, the compounds 3a–d were obtained
and analysed by TGA in order to evaluate the percentage of the
loading, that was in the range among 0.6–2.9%.
It is interesting to note that, upon increasing the alkyl chain
length of thiol (from 3a to 3d), we obtained materials with lower
percentage loading (2.9 and 0.9%, respectively), as a conse-
quence of enhanced steric hindrance on the HNT surface.
The grafting degrees provided an idea in terms of average
positions substituted in the CD, namely it comes out that in
3a and 3b the allyl groups have been fully substituted while 3c
and 3d have an average of two substituted allyl groups.
The new materials were characterized by FT-IR spectroscopy,
TGA and SEM measurements.
FT-IR investigation of 3a–d shows that the vibrational bands
of HNTs remain unaltered after the reactions. The frequency
and assignments of each vibrational mode are based on pre-
vious reports on halloysite.18
Compared to 1 compounds 3a–d exhibit an increase in the
intensity of vibration bands for C–H stretching of methylene
groups at around 2960 cm1 and 2865 cm1 (see ESI†).
The samples 3a–d were investigated by means of TGA to
determine the grafted amount of organic moieties. From a
comparison with the thermogram of 1, a further degradation
and volatilization is observed accounting for the additional
organic fraction. The grafting degrees were determined by
comparing the residual masses at 900 1C of each 3a–d and 1.
The obtained values are rather similar and range between
0.6 and 2.9 wt%.
Direct observation of the surface morphology of 3a–d was
accomplished by SEM. In all cases, the tubular shape of the
nanoclay is not lost after grafting. Moreover, the lumen of the
functionalized nanotubes appears empty, in agreement with
the expected grafting at the external surface (Fig. 2).
Studies of the dispersions in aqueous medium
Turbidimetric analysis was performed to highlight the influ-
ence of functionalization on the dispersion stability of HNTs in
aqueous media, which might be crucial for its application as
a drug delivery system. Dispersions of 3a–c showed a lower
stability in water than 1, according to the more hydrophobic
surface functionalization in 3a–b as compared to 1 (Fig. 3).
In contrast, dispersions of 3d showed higher aqueous stability
(Fig. 3) than 3a–b and, surprisingly, even than 1.
It is known19 that the presence of the polymer and/or the
surfactant at the nanoparticle surface may, generally, cause two
diﬀerent eﬀects: (i) hydrophobic interactions that involve aggre-
gation of material; (ii) steric repulsion or osmotic eﬀects that
involve an increase in repulsive interactions between nanoparticles
and this generates stabilization of the dispersions.
The stability of the dispersions of compounds 3a–c is controlled
by hydrophobic interactions, while for 3d a steric stabilization
may occur.
Fig. 1 Halloysite nanotube–amphiphilic cyclodextrin drug carrier.
Scheme 1 Schematic representation for the linkage of alkyl thiols on
compound 1.
Fig. 2 SEM images of 3a.
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The diﬀusion coeﬃcient of the nanoparticles in the solvent
confirmed the results obtained by turbidimetric analysis. The
diﬀusion coeﬃcients of 3a–d obtained by DLS experiments are
collected in Table 1.
By comparing these results with the diﬀusion coeﬃcient of 1
(11  1013 m2 s1) and HNTs in water (9.4  1013 m2 s1)20
it appears that 3a–b form aggregates while 3c–d show no
aggregation.
With the aim of evidencing possible changes in the nano-
particle–nanoparticle electrostatic interactions, the z-potential
in water was measured. All samples 3a–d showed negative
z-potential values (ca. 20 mV) close to that of HNTs (19.5 mV).
Therefore the electrostatic nanoparticle–nanoparticle repulsions
are not altered by the surface functionalization, confirming that
the aggregation of 3a–b compounds is driven by van der Waals
interaction and hydrophobic effects.
Interaction with silibinin and quercetin
With the aim of combining two or more drugs with synergistic
therapeutic eﬀects we verified the binding abilities of one of
our new systems (3a) for two flavonoids, namely, silibinin (Sil)
and quercetin (Que), chosen for their diﬀerent aﬃnities for the
two cavities of the nanomaterial. We choose for the subsequent
studies the 3a compound in order to overcome problems of
native CDs that limit their applications in pharmaceutical
fields, for example to (i) enhance the interaction of CDs with
biological membranes and (ii) modify or enhance interaction of
CDs with hydrophobic drugs.21 It should be noted that 3a has
the highest loading (2.9%) of amphiphilic cyclodextrins.
Experimental investigations performed by means of UV-vis
and HPLC highlighted that silibinin did not interact with the
cyclodextrin cavity, in contrast, it was encapsulated into the
pristine HNT lumen as found by UV-vis spectroscopy and TGA
(see ESI†).
It is reported that native bCD is eﬃcient in including
quercetin.22 In order to verify that the CD modification does
not hinder the quercetin inclusion, supramolecular inter-
actions with amphiphilic CDs (having the same substitution
pattern of 3a) have been studied. The formation of 1 : 2 quercetin/
amph-CD complexes has been demonstrated by isothermal
titration calorimetry (ITC) and UV-vis spectroscopy. The ITC
data provided the equilibrium constant and the enthalpy
change for the quercetin–amph-CD inclusion complex formation
by assuming the equilibria:
CDþQue ! 
K1
CDQue
CDQueþ CD ! 
K2
CDQue CD
and the procedure reported elsewhere.23
It was found b = K1  K2 = (6.3  0.3)  105 M2 and DHic =
7.1  0.3 kJ mol1, according to UV-vis results (b = (9  2) 
105 M2) (see ESI† for details).
Furthermore fluorescence titration showed that this mole-
cule also interacts with pristine HNTs (see ESI†). Recently, we
have demonstrated that in the presence of HNT–cyclodextrin
hybrids, curcumin, a biological molecule with a similar struc-
ture to quercetin, interacts preferentially with the cyclodextrin
cavity.11
On the ground of this evidence we studied the interaction of
3a with silibinin and quercetin by HPLC and fluorescence
spectroscopy.
Reverse-phase HPLC equipped with a Diode-Array/UV detector
oﬀers the remarkable advantage of recording in real time the
UV-vis spectrum of the chromatographic eluate (in the range of
200–600 nm), and therefore it allows the simultaneous moni-
toring of different species/analytes.
According to previous reports,24 pure silibinin showed two
peaks in the HPLC chromatogram, corresponding to the dia-
steroisomers silibinin A and B, with retention times (rt) of 2.67
and 3.53 minutes, respectively (eluent MeOH/H2O 90 : 10 v/v,
flow 1 mL min1). The most abundant component displayed
two bands in the UV spectrum, the first one at 280 nm and the
second one, less intense, at ca. 320 nm.
Pure quercetin showed one peak in the chromatogram at a rt
of 3.38 min and it showed an UV spectrum with two bands at
250 and 370 nm.
No peaks were observed in the chromatogram related to 3a,
because this material showed no UV absorption.
Titration of fixed concentrations of silibinin and quercetin
with 3a (0–1.8 mg mL1) gave chromatograms (eluent MeOH/
H2O 90 : 10 v/v, flow 1 mLmin
1) which illustrated an unresolved
broad peak at the rt range between 3.00 and 3.50 min, and
presented a UV spectrum showing the same absorption maxima
of silibinin. However, with the increasing amount of 3a the UV
spectrum displays a drastic change in the intensity of signal at
320 nm (Fig. 4).
Fig. 3 Optical transmittance as a function of time for 1 and 3a–d dispersions
in water. The concentration is 0.1 wt% in all cases.
Table 1 Diﬀusion coeﬃcients for modified HNTs
Entry Sample D (1013 m2 s1)
1 3a 5.57
2 3b 5.93
3 3c 9.53
4 3d 9.01
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It is known that dihydroflavonols show two major absorp-
tion bands: band I (300–400 nm) and band II (240–280 nm).25
Band I originates due to the light absorption of the A + C rings
and corresponds to a p–p* transition; band II is due to the
absorption of the B ring.
Therefore, because in our systems we have hypothesized
that silibinin interacts with 3a lumen, the diﬀerent UV electro-
nic absorption behaviour may be attributed to specific Sil–3a
interactions in the form of hydrogen bonds and/or hydrophobic
effects that involve phenolic OH groups of A rings. Similar
results were obtained by Angelico et al. for the encapsulation of
silibinin into liposomes.26
Being that silibinin in aqueous medium does not show
emission, the interaction of quercetin and 3a, in contrast,
was studied by means of fluorescence spectroscopy.
The trend of fluorescence intensity of quercetin (1  104 M),
recorded at 540 nm, with the increasing amount of 3a
(0–1.5 mg mL1) is reported in Fig. 5. This trend, related to
the surnatant of the dispersions, is close to that obtained in the
presence of crude amph-CD. Based on this finding and on the
strong interaction evidenced by ITC and UV-vis between Que
and amph-CD, one may hypothesize that quercetin interacts
preferentially with the cyclodextrin cavity (Fig. 5). Similarly,
curcumin, a hydrophobic drug, was selectively incapsulated
into the CD instead of the hydrophilic HNT cavity.11
Loading silibinin into 3a was carried out by vacuum cycling
of a 3a suspension in a saturated silibinin solution. This cycle
was repeated several times in order to obtain the highest loading
eﬃciency. After loading, the 3a–Sil complex was washed in order
to remove the free silibinin. 3a–Sil was suspended again in water
and then to this dispersion a saturated solution of quercetin
was added. Subsequent investigations were conducted on the
dry solid filtered from dispersion, washed with water and dried
overnight at 60 1C.
The composite solids 3a–Sil and 3a–Sil–Que were character-
ized by TGA (Fig. 6). The thermoanalytical curves clearly show
the successful loading of the drugs at each step. Given that both
silibinin and quercetin degraded with a null residual at 900 1C,
we calculated that compound 3a is able to incorporate 6.1%
of silibinin and 2.2% of quercetin. These results prove that
the modified HNTs with a double cavity are efficient as nano-
containers for the co-delivery of two biological active molecules.
Kinetic release
In Fig. 7, an extended release profile of silibinin and quercetin
from 3a, in two diﬀerent pH solutions, is shown.
The release of silibinin at pH 1 from compound 3a reaches a
plateau after 400 min, and an initial burst is observed within
200 min followed by a prolonged release.
The release profile obtained for quercetin showed a similar
behavior to silibinin, but in this case a very low amount of
molecule was released from the system (Fig. 7a). These results
could be explained as follows. In acidic solution both 3a and
silibinin are positively charged; therefore, electrostatic repul-
sions may also accelerate the release of the drug from 3a. In the
case of quercetin it was reported that the retention eﬃciency of
Que on b-CD is dependent on the pH, in particular it was larger
in acidic solution than in neutral and basic media.27 Therefore,
the small amount of quercetin released from 3a at pH 1 could
be explained on the basis of strong interaction of the molecules
and the CD cavity in acidic medium.
Fig. 4 UV-vis spectra of (a) silibinin and (b) 3a–silibinin complex.
Fig. 5 Trend of the fluorescence intensity of quercetin, recorded at 540 nm,
as a function of 3a concentration (0–1.8 mg mL1) in the presence of a fixed
amount of silibinin (1  104 M); the inset shows the fluorescence intensity of
quercetin in the presence of increasing amounts of b-CD.
Fig. 6 Thermoanalytical curves for 3a before and after drug loading.
Fig. 7 Amount of silibinin and quercetin released from 3a in (a) 0.1 M HCl
solution; (b) pH 7.4 phosphate buﬀer.
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In physiological medium, we observed that both molecules
were released from the system; also in this case, quercetin was
released in a smaller amount than silibinin. The diﬀerent
release in a neutral medium could be explained by taking into
account that flavonoids are in their neutral form in a pH range
between 4 and 6; therefore at physiological pH they could be
partially dissociated and so more soluble in aqueous medium.
To better understand the release behaviour of silibinin and
quercetin in diﬀerent pH situations, the in vitro release data
were fitted to various models to analyse the kinetics and the
release mechanism of both molecules. The experimental data
were analysed using the zero-order and first order equation,
the double exponential model (DEM) and the Power law, to
elucidate the release kinetics of silibinin at pH 1 and 7.4 and
of quercetin at pH 7.4. It was found that the release mode
of silibinin in acidic solution follows the double exponential
model. According to the literature,28 the DEM describes a
mechanism consisting of two parallel reactions involving two
spectroscopically distinguishable species. In our particular case,
we observed the release of silibinin and the simultaneous, even
if it is very low, release of quercetin (k = 0.007  0.001 min1 and
k0 = 0.064  0.006 min1).
In physiological medium, release mode of silibinin and
quercetin follows, in both cases, the first-order kinetics
(k = 0.0017  0.0001 min1 and 0.0007  0.0001 min1, for
silibinin and quercetin, respectively).
Desorption of silibinin and quercetin from 3a can be
described as the desorption of the molecules encapsulated into
the HNT lumen and into the b-CD cavity, respectively.
In vitro cytotoxicity assay
We have tested the potential anti-proliferative in vitro activity of
the 3a–Sil–Que complex on an anaplastic thyroid cancer cell
line: 8505C by means of MTS tests.
The survival rates of the tumor cells incubated with 3a at
each concentration were found in the range of 96–100%,
indicating that they have no effect on the cell viability of
the tumor cell lines under the concentration conditions inves-
tigated. Free quercetin and silibinin have no effect on cell
viability, probably due to their rapid metabolism, systemic
elimination and insolubility in physiological medium.
In contrast, the cell line showed a dose dependent cytotoxic
profile when subjected to the treatment of 3a–Sil–Que (see
Fig. 8).
In particular, the concentration of 3a–Sil–Que which caused
50% inhibition of cell growth was 27.6  6.1 mM Compared to
the free drugs, the HNT nanoparticles significantly improved
the cellular cytotoxicity and exhibited the obviously synergistic
effect by the co-delivery of two different anticancer drugs,
silibinin and quercetin.
Cellular uptake of the drug into 3a
In the light of the potential application of 3a–Sil–Que as the
novel therapeutic treatment, several tests have been carried out
in vitro to evaluate their uptake and localization into 8505C
thyroid cancer cell lines. Indeed, for the internalization of
nanoparticles by tumor cells it is essential to liberate therapeutic
agents into the cytosol where most therapeutic agents accumu-
late and exhibit effect.
For this purpose, we analyzed, by means of fluorescence
microscopy, the interaction between cells and the carrier.
Fluorescence microscopy data revealed that 3a showed a
high propensity to cross cell membranes resulting in a massive
cell uptake, as highlighted by the fluorescence emission loca-
lized in the cytoplasm. In particular, halloysite nanoparticles
penetrate into the cells and concentrate around the cell nucleus
from the observation of the silibinin fluorescence signal (green)
within cells (Fig. 9). The results suggested that the 3a–Sil–Que
complexes could be effectively transported into living cells.
Experimental section
All needed reagents were used as purchased (Aldrich), without
further purification.
Cyclodextrin functionalized HNTs were prepared according
to the previous report.11
Fig. 8 MTS test for the cell viability of 8505C cells cultured for 72 h in the
presence of 3a–Sil–Que.
Fig. 9 Fluorescence microscopy images of the 3a uptake by 8505C.
8505C cell membrane (red) with co-localised 3a (green) outside nuclei
at (a) 1 h and (b and c) 24 h.
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Heptakis-6-(tert-butyldimethylsilyl)-2-propaneoxy-2-hexanethio-
b-cyclodextrin was synthesized as described below.
The chromatographic measurements were performed using
a Shimadzu Class VP (Shimadzu, Japan) which consists of a
pump (LC-10AD VP Shimadzu), an injection valve equipped
with a 20 mL injection loop, an UV-vis Diode-Array (SPD-M10A
VP) and an acquisition data software Class-VP. After optimiza-
tion of chromatographic conditions, separation was carried out
in a C18 column (Discovery Supelco, 25 cm  4.6 mm, 5 mm).
The mobile phase consisted of methanol/water 90 : 10 v/v, at
room temperature, flow 1 mL min1.
An AESEM FEI QUANTA 200F microscope apparatus was
used to study the morphology of the functionalized HNTs.
Before each experiment, the sample was coated with gold under
argon by means of an Edwards Sputter Coater S150A, in order
to avoid charging under electron beam.
Thermogravimetric analyses were performed on a Q5000 IR
apparatus (TA Instruments) under a nitrogen flow of 25 cm3
min1 for the sample and 10 cm3 min1 for the balance. The
weight of each sample was ca. 10 mg. Measurements were
carried out by heating the sample from rt up to 900 1C at a
rate of 10 1C min1.
IR spectra (KBr) were recorded using an Agilent Techno-
logies Cary 630 FT-IR spectrometer. Specimens for measure-
ments were prepared by mixing 5 mg of the sample powder
with 100 mg of KBr.
DLS measurements were performed at 22.0  0.1 1C in a
sealed cylindrical scattering cell at a scattering angle of 901, by
means of a Brookhaven Instrument apparatus composed of an
BI-9000AT correlator and a He–Ne laser (75 mW) at a wave-
length (l) of 632.8 nm. The solvent was filtered through a
0.45 mm pore size Millipore filter. For all systems, the field-time
autocorrelation functions were well described by a mono-
exponential decay function, which provides the decay rate (G)
of the single diffusive mode. For the translational motion, the
collective diffusion coefficient at a given concentration is Dt =
G/q2 where q is the scattering vector given by 4pnl1 sin(y/2),
n is the water refractive index and y is the scattering angle.
Turbidimetric and UV-vis measurements were performed
using a Beckmann DU 650 spectrometer.
The ITC experiments were carried out at 298 K by means of a
nano-ITC200 calorimeter (MicroCal). An amount of approxi-
mately 40 mL of quercetin solution (2 mmol dm3) was injected
into the thermally equilibrated ITC cell (202 mL) filled with the
CD solution (0.1 mmol dm3). The solvent was phosphate
buﬀer (pH = 6.9)/MeOH 6 : 4. The heat eﬀect was measured
after each addition of 2 mL and corrected by dilution eﬀects.
The dispersions were sonicated using an ultrasound bath
VWR Ultrasonic Cleaner (power 200 W and frequency 75 MHz).
z-Potential measurements were performed by means of a
ZETASIZER NANO ZS90 (Malvern Instruments).
Steady-state fluorescence spectra were acquired using a
JASCO FP-777W spectrofluorimeter. Excitation and emission
slits were 1.5 and 3 nm, respectively, the excitation wave-
length was 372 nm and the emission interval was between
300 and 750 nm.
Synthesis of heptakis-6-(tert-butyldimethylsilyl)-2-propaneoxy-
2-hexanethio-b-cyclodextrins
In a quartz test tube the heptakis-6-(tert-butyldimethylsilyl)-2-
allyloxy-b-cyclodextrin29 (100 mg, 46.2 mmol, 1 eq.) and hexa-
nethiol (0.23 mL, 1.62 mmol, 35 eq.) were dissolved in distilled
95% toluene/MeOH (the concentration of CDs was 5 mM).
A stream of Ar was bubbled through the solution for 15 min
to thoroughly degas it. The test tube, maintained under an
atmosphere of Ar, was placed in front of a Hg lamp (265 nm)
and stirred for 20 h. Following removal of solvent, the residue
was washed three times with hexane and purified by chromato-
graphy (SiO2, from 100% hexane/EtOAc to 50% hexane/EtOAc)
to aﬀord the product as a white solid (yield 82%).
1H NMR (DMSO, 300 K, 300 MHz) d: 0.2 (42H, s), 0.88 (21H, t,
J = 9.5 Hz), 0.98 (63H, s), 1.30 (28H, m), 1.42 (14H, m), 1.63 (14H,
m), 1.90 (14H, m), 2.68 (14H, m), 2.79 (14H, m), 3.37 (14H, t,
J = 7.4 Hz), 3.02 (7H, dd, J = 3.0 Hz, J = 9.5 Hz), 3.54 (14H, m), 3.59
(7H, bs), 3.79 (7H, m), 3.99 (14H, m), 4.94 (7H, d, J = 3.3 Hz).
13C NMR (DMSO, 300 K, 75 MHz) d: 4.9, 14.1, 22.7, 25.9, 28.2,
30.6, 30.8, 31.1, 33.2, 73.5, 62.5, 74.4, 74.9, 75.9, 79.7, 102.0.
Synthesis of compounds 3a–d
The appropriate thiol 2a–d (1000 eq.) and modified HNT 1
(100 mg) were dissolved in anhydrous toluene. A stream of Ar
was bubbled through the solution for 15 min to thoroughly
degas it. The solution, maintained under an atmosphere of Ar,
was placed in front of a Hg lamp and stirred for 24 h. Following
removal of solvent, the precipitate was washed with CH2Cl2 and
dried overnight at 80 1C under vacuum.
General procedure to obtain 3a/biological molecule dispersions
Various weighed amounts of p-HNT or 3a (from 2 up to 14 mg)
were dispersed by sonication for 5 minutes in H2O, at an
ultrasound power of 200 W and a temperature of 25 1C. 1 mL
of appropriate biological molecule solution (1  104 M) in a
mixture of pH 6.9 buﬀer/EtOH (6 : 4) was added to the p-HNT or
3a dispersions. The final volume was 10 mL.
General procedure to obtain solid complexes
To a dispersion of 3a in deionized water (5 mL), 1 mL of silibinin
solution 102 M in ethanol was added. The suspension was
sonicated for 5 min, at an ultrasound power of 200 W and at
25 1C and then was evacuated for 3 cycles. The suspension was left
under stirring for 24 h at room temperature. After this time the
powder was washed with water and then dried at 80 1C under
vacuum. Afterwards the 3a–silibinin solid complex was suspended
again in deionized water (5 mL) and 1 mL of quercetin solution
(102M) in ethanol was, then, added. The suspension was stirred for
4 days at rt and then was filtered; the powder was washed with small
amounts of water and then dried at 70 1C under vacuum overnight.
General procedure for spectrophotometric measurements
Measurement solutions were prepared by adding increasing
volumes of the solution of heptakis-6-(tert-butyldimethylsilyl)-2-
propaneoxy-2-hexanethio-b-cyclodextrins in phosphate buﬀer
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(pH 6.9) (1.2  103 M) to 100 mL of the quercetin aqueous
solution into a volumetric flask. In these solutions, the concen-
trations of the quercetin were constant and equal to 1  105 M
while the concentration of the heptakis-6-(tert-butyldimethyl-
silyl)-2-propaneoxy-2-hexanethio-b-cyclodextrin increased from
1.2  104 M up to 1.08  103 M. The absorbance was
recorded at 370 nm and spectroscopic data were fitted using
the following equation (the non-linearized version of Benesi–
Hildebrand treatment):
CDþQue ! 
K1
CDQue
CDQueþ CD ! 
K2
CDQue CD
DA ¼ De  b Que  ½CD
2
1þ b  ½CD2 (1)
b = K1K2
where De is the diﬀerence of the extinction molar coeﬃcient of
free and complexed quercetin, and Que and CD are the total
concentration of the quercetin and the heptakis-6-(tert-
butyldimethylsilyl)-2-propaneoxy-2-hexanethio-b-cyclodextrin,
respectively.
Kinetic release
The release of quercetin and silibinin from the 3a–Sil–Que
complexes was done as follows: 25 mg of the sample were
dispersed in 1 mL of dissolution medium and transferred into a
dialysis membrane (Medicell International Ltd MWCO 12-14000
with a diameter of 21.5 mm). Subsequently the membrane was
put in a round bottom flask containing 10 mL of the release
medium at 37 1C and stirred.
Two diﬀerent media (0.1 M HCl and phosphate buﬀer pH 7.4,
respectively) were considered in order to evaluate the influence
of pH on the release behavior of the drug.
At fixed time, 1 mL of the release medium has been with-
drawn and analyzed by UV-vis (at 250 and 290 nm for quercetin
and silibinin, respectively). To keep constant the volume of the
release medium, 1 mL of fresh solution (0.1 M HCl, pH 7.4
buﬀer) has been used to replace the collected one.
The quercetin and silibinin concentrations in the solution
were determined by UV-vis spectrophotometry using the
Lambert–Beer law.
Total amounts of drug released (Ft) were calculated as follows:
Ft ¼ VmCt þ
Xt1
i¼0
VaCi (2)
where Vm and Ct are the volume and the concentration of the
drug at time t. Va is the volume of the sample withdrawn and Ci is
the drug concentration at time i (i o t).
Cell culture
8505c anaplastic thyroid cancer cells (ECAC Sigma-Aldrich,
Milan, Italy) were grown in RPMI1640 (Sigma-Aldrich, Milan, Italy)
supplemented with 10% FCS (Sigma-Aldrich, Milan, Italy),
2 mM L-glutamine and penicillin–streptomycin and incubated
at 37 1C in 5% CO2 and 100% humidity.
MTS assay
8505c cells were plated at 1500 cells per well in triplicate in a
96-well plate. After 24 h of incubation, 3a–Sil–Que drug suspen-
sion was added ranging from 100 mM to 0.391 mM. After 72 h of
incubation the plate was washed with sterile PBS, to avoid
colour interference from the 3a–Sil–Que compound. 20mL of the
CellTiter 96 AQueous One Solution (Promega, Milan, Italy) was
added, and the plate was incubated for 4 hours at 37 1C. The
absorbance at 490 nm was recorded using a plate reader
(Multiskant TC Microplate Photometer, Thermo SCIENTIFIC,
Milan Italy). The results were expressed as % of viability with
respect to the control cells that were not treated.
IC50 was calculated by Global Optimization using Simulated
Annealing Software (GOSA-fit) and was found to be 27.6  6.1 mM.
Fluorescence microscopy
8505c cells were seeded in a Nunc Lab-Tek Chamber Slide
(Nunc, Italy) at a density of 300 000 cells per slide in RPMI
culture medium and incubated under standard conditions.
After 24 hours 3a was added at 10 mM and incubated for 1 hours
and 24 hours, respectively. Slides were then extensively washed
with PBS-containing Ca and Mg and counterstained with Evans
Blue in PBS at 0.005%. Slides were observed using a Zeiss
Axiophot fluorescence microscope with a FITC filter equipped
with a Nikon DS-Fi1 CCD-camera.
Conclusions
We have developed a new nanocarrier composed of biodegrad-
able halloysite nanotube–amphiphilic cyclodextrins for the
co-delivery of silibinin and quercetin as a potential combi-
nation therapy for the treatment of thyroid cancer.
Multicavity halloysite-nanotube materials were obtained by
grafting amphiphilic cyclodextrin units onto the nanotube
surface. The obtained materials were characterized by FT-IR
spectroscopy, and TGA and SEM investigations.
In order to exploit their ability as drug carriers we, also,
performed turbidimetric analysis in aqueous medium, which
showed that, depending on the alkyl chain length of alkyl groups
on cyclodextrins, the materials were like aggregates. These results
were confirmed by DLS and z-potential investigations.
We studied the binding abilities of the systems with two
biologically active molecules, namely quercetin and silibinin.
HPLC measurements and fluorescence spectroscopy high-
lighted that silibinin interacts preferentially with the HNT
lumen, while quercetin does with the cyclodextrin cavity.
The kinetic release of the two molecules from the multicavity
system was also carried out. In addition, TGA results showed that
the new materials can load with eﬃciency the drugs and there-
fore, they are suitable nanocontainers for co-delivery of two drugs
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that could have synergic eﬀects in anticancer therapy as demon-
strated by in vitro cytotoxicity assays.
Finally, the interaction between cells and the carrier, ana-
lyzed by fluorescence microscopy, revealed that the materials
were uptaken into cells surrounding the nuclei. Therefore the
multicavity systems could transport drugs into living cells.
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